BRPI0716046A2 - composiÇÕes de nanopartÍcula. - Google Patents

composiÇÕes de nanopartÍcula.

Info

Publication number: BRPI0716046A2
Authority: BR; Brazil
Prior art keywords: nanoparticle compositions; nanoparticle; compositions
Prior art date: 2006-08-17

Application number

BRPI0716046-1A2A

Other languages

English (en)

Inventor

Saran Kumar

Wen-Chung Shieh

Seema Tomer

Joseph Lawrence Zielinski

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-17

Filing date

2007-08-15

Publication date

2013-09-17

2007-08-15 Application filed by Novartis Ag filed Critical Novartis Ag

2013-09-17 Publication of BRPI0716046A2 publication Critical patent/BRPI0716046A2/pt

Links

239000000203 mixture Substances 0.000 title 1
239000002105 nanoparticle Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Biomedical Technology (AREA)
Optics & Photonics (AREA)
Nanotechnology (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0716046-1A2A 2006-08-17 2007-08-15 composiÇÕes de nanopartÍcula. BRPI0716046A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US82267406P	2006-08-17	2006-08-17
PCT/US2007/075968 WO2008060734A2 (en)	2006-08-17	2007-08-15	Nanoparticle compositions

Publications (1)

Publication Number	Publication Date
BRPI0716046A2 true BRPI0716046A2 (pt)	2013-09-17

Family

ID=39313134

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0716046-1A2A BRPI0716046A2 (pt)	2006-08-17	2007-08-15	composiÇÕes de nanopartÍcula.

Country Status (15)

Country	Link
US (1)	US20100166865A1 (pt)
EP (1)	EP2054043A2 (pt)
JP (1)	JP2010501004A (pt)
KR (1)	KR20090041437A (pt)
CN (1)	CN101500546A (pt)
AR (1)	AR062452A1 (pt)
AU (1)	AU2007319701A1 (pt)
BR (1)	BRPI0716046A2 (pt)
CA (1)	CA2659407A1 (pt)
CL (1)	CL2007002371A1 (pt)
MX (1)	MX2009001630A (pt)
PE (1)	PE20080899A1 (pt)
RU (1)	RU2009109353A (pt)
TW (1)	TW200815047A (pt)
WO (1)	WO2008060734A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2915692T3 (es)	2008-08-13	2022-06-24	California Inst Of Techn	Nanopartículas portadoras y composiciones, métodos y sistemas relacionados
US8889193B2 (en)	2010-02-25	2014-11-18	The Johns Hopkins University	Sustained delivery of therapeutic agents to an eye compartment
US20130195764A1 (en) *	2010-04-21	2013-08-01	President And Fellows Of Harvard College	Nanoparticle Targeting to Ischemia for Imaging and Therapy
WO2011159951A2 (en) *	2010-06-17	2011-12-22	Sanford-Burnham Medical Research Institute	Targeting tumor associated macrophages using bisphosphonate-loaded particles
WO2012109363A2 (en)	2011-02-08	2012-08-16	The Johns Hopkins University	Mucus penetrating gene carriers
WO2013105026A1 (en)	2012-01-09	2013-07-18	Department Of Biotechnology (Dbt)	A process for preparing solid lipid sustained release nanoparticles for delivery of vitamins
EP2625966A1 (en)	2012-02-13	2013-08-14	Bionanoplus, S.L.	Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
US10568975B2 (en) *	2013-02-05	2020-02-25	The Johns Hopkins University	Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
US9468681B2 (en)	2013-03-01	2016-10-18	California Institute Of Technology	Targeted nanoparticles
CA3166758A1 (en)	2013-05-14	2014-11-20	California Institute Of Technology	Method of delivering therapeutics and imaging agents by nanoparticles that cross the blood brain barrier
WO2015175545A1 (en)	2014-05-12	2015-11-19	The Johns Hopkins University	Highly stable biodegradable gene vector platforms for overcoming biological barriers
JP6846351B2 (ja)	2015-01-27	2021-03-24	ザ・ジョンズ・ホプキンス・ユニバーシティー	粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤
EP3317323B1 (en)	2015-07-01	2021-05-26	California Institute of Technology	Cationic mucic acid polymer-based delivery systems
US10786465B2 (en)	2015-07-27	2020-09-29	The Texas A&M University System	Polymer/copolymer nanoparticles conjugated to gambogic acid
WO2017100533A1 (en) *	2015-12-09	2017-06-15	Board Of Regents, The University Of Texas System	Polymeric drug delivery systems for treatment of disease
US20190381188A1 (en)	2018-06-13	2019-12-19	California Institute Of Technology	Nanoparticles For Crossing The Blood Brain Barrier And Methods Of Treatment Using The Same
WO2020210805A1 (en)	2019-04-11	2020-10-15	The Johns Hopkins University	Nanoparticles for drug delivery to brain
WO2021113643A2 (en)	2019-12-04	2021-06-10	Dantari, Inc.	Methods and compositions for synthesis of therapeutic nanoparticles
CN116808202B (zh) *	2023-04-28	2025-08-01	苏州大学	一种纳米硼递送剂及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999018934A1 (en) *	1997-10-09	1999-04-22	Vanderbilt University	Micro-particulate and nano-particulate polymeric delivery system
US7008645B2 (en) *	1998-07-14	2006-03-07	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Method of inhibiting restenosis using bisphosphonates
US6558702B2 (en) *	2001-04-13	2003-05-06	Alkermes Controlled Therapeutics, Inc.	Method of modifying the release profile of sustained release compositions
KR100648515B1 (ko) *	2004-05-04	2006-11-27	(주)아모레퍼시픽	비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제
NZ550856A (en) *	2004-05-06	2010-11-26	Samyang Corp	Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylactic acid derivative
WO2006102117A1 (en) *	2005-03-17	2006-09-28	Elan Pharma International Limited	Nanoparticulate biphosphonate compositions

2007
- 2007-08-15 BR BRPI0716046-1A2A patent/BRPI0716046A2/pt not_active Application Discontinuation
- 2007-08-15 MX MX2009001630A patent/MX2009001630A/es not_active Application Discontinuation
- 2007-08-15 RU RU2009109353/15A patent/RU2009109353A/ru not_active Application Discontinuation
- 2007-08-15 US US12/376,458 patent/US20100166865A1/en not_active Abandoned
- 2007-08-15 EP EP07868331A patent/EP2054043A2/en not_active Withdrawn
- 2007-08-15 PE PE2007001099A patent/PE20080899A1/es not_active Application Discontinuation
- 2007-08-15 KR KR1020097005377A patent/KR20090041437A/ko not_active Withdrawn
- 2007-08-15 JP JP2009524777A patent/JP2010501004A/ja active Pending
- 2007-08-15 CA CA002659407A patent/CA2659407A1/en not_active Abandoned
- 2007-08-15 AR ARP070103620A patent/AR062452A1/es unknown
- 2007-08-15 WO PCT/US2007/075968 patent/WO2008060734A2/en not_active Ceased
- 2007-08-15 AU AU2007319701A patent/AU2007319701A1/en not_active Abandoned
- 2007-08-15 CN CNA2007800298042A patent/CN101500546A/zh active Pending
- 2007-08-16 TW TW096130347A patent/TW200815047A/zh unknown
- 2007-08-16 CL CL200702371A patent/CL2007002371A1/es unknown

Also Published As

Publication number	Publication date
TW200815047A (en)	2008-04-01
KR20090041437A (ko)	2009-04-28
WO2008060734A2 (en)	2008-05-22
RU2009109353A (ru)	2010-09-27
JP2010501004A (ja)	2010-01-14
US20100166865A1 (en)	2010-07-01
EP2054043A2 (en)	2009-05-06
MX2009001630A (es)	2009-02-23
PE20080899A1 (es)	2008-06-25
CL2007002371A1 (es)	2008-08-08
CN101500546A (zh)	2009-08-05
CA2659407A1 (en)	2008-05-22
WO2008060734A3 (en)	2008-07-10
AR062452A1 (es)	2008-11-12
AU2007319701A1 (en)	2008-05-22

Legal Events

Date	Code	Title	Description
2013-12-31	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2014-04-29	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]

Publication	Publication Date	Title
FR2909857B1 (fr)	2009-03-06	Endovalve.
DE602007009284D1 (de)	2010-10-28	3-aza-bicycloä3.1.0ühexanderivate
ATE469145T1 (de)	2010-06-15	4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-
BRPI0716325A2 (pt)	2014-03-04	Composição antimicrobianas
BRPI0720216A2 (pt)	2013-12-24	Composições microbicidas
ATE513831T1 (de)	2011-07-15	Pyridinä3,4-büpyrazinone
CR10841A (es)	2009-06-30	Imidazotriazinas imidazopirimidinas inhibidores de cinasa
BRPI0923047A2 (pt)	2015-12-08	"conjugados de proteínas-oligossacarídeos".
EP2043136A4 (en)	2010-08-11	FILMING COMPOSITION
FR2899996B1 (fr)	2014-07-04	Disjoncteur.
BRPI0716458A2 (pt)	2014-03-04	Composição de vulcanizado
DE602007001681D1 (de)	2009-09-03	1,3-dioxan-carboxylsäuren
FR2899479B1 (fr)	2009-07-24	Composition cicatrisante
BRPI0718141A2 (pt)	2013-11-05	Composições de frangrâncias
BRPI1014207A2 (pt)	2016-04-05	"trasmissão."
EP2197828A4 (en)	2011-09-21	FULLEREN-MULTIADDUKT COMPOSITION
FR2900034B1 (fr)	2012-08-17	Poudrier.
BRPI0814748A2 (pt)	2015-03-03	Compostos de alditóis substituídos, composições e métodos
FR2905563B1 (fr)	2008-12-05	Composition alimentaire.
FR2923713B1 (fr)	2010-09-10	Composition reductrice epaissie.
EP1986635A4 (en)	2009-04-22	ANTI CANCER AGENTS
BRPI0922256A2 (pt)	2015-12-29	composições de nanopartículas
FR2898899B1 (fr)	2012-09-28	Composition photoreticulable
PT2444812E (pt)	2016-03-11	Métodos de imunoensaio melhorados
FR2909834B1 (fr)	2011-04-01	Andaineuse transversale.